BioCrea GmbH

Getting drugs across the blood-brain barrier has proven to be a challenge for many drug developers, from tiny start-ups to multinational companies. If ArmaGen Technologies Inc. has the answer – or

Financings In the first quarter of 2012, biopharma start-ups raised $338.1 million – 51% less than the previous quarter but a 62% hike from Q1 2011. Series B rounds dominated, generating 43% of the to

IN VITRO DIAGNOSTICS Mergers & Acquisitions Alere Inc. eScreen Inc. Point-of-care diagnostics company Alere Inc. has acquired private drugs-of-abuse screening firm eScreen Inc. for $270mm in c

Specific phosphodiesterase inhibitors for CNS diseases Meissner Strasse 191 01445 Radebeul, Germany Phone: +49 351 40 430 Web Site: www.biocrea.com Contact: Thomas Kronbach, PhD, CEO Industry Segment: